Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.
about
MicroRNA expression, survival, and response to interferon in liver cancerEffect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic reviewManagement before hepatectomy for hepatocellular carcinoma with cirrhosisPotentiality of immunotherapy against hepatocellular carcinomaManagement of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinomaNucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysisThrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysisEffects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesAssociation of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort studyPostoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyAdjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitisUp-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trialHepatocellular carcinoma: insight from animal models.Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.New progress of non-surgical treatments for hepatocellular carcinoma.Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomyRole of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma.Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis.Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma.Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation.Multidisciplinary treatment of patients with hepatocellular carcinoma.The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma.Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma.A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma.Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy.Clinical features of hepatitis B virus-related hepatocellular carcinoma.Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Adjuvant therapy after curative treatment for hepatocellular carcinoma.Translational medicine in hepatocellular carcinoma.Prevention of recurrence after curative treatment for hepatocellular carcinoma.Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials.A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma.
P2860
Q24647241-3371B86D-D97F-4189-B77C-A3A48769C406Q26747293-35B600BF-321E-4CEA-8503-4CB7A1DD3C05Q26783874-AE833097-BAB4-42E8-8558-1825EA13C45CQ26784228-4FC04EA5-CC76-4548-9920-407659516A57Q26799056-65171DFC-7A0D-48AE-86BA-A4FF96662213Q26998178-8FD8D85B-9C83-4872-A181-066CD67F4D8FQ26998730-45A6F16F-D3E2-4F7F-9A1A-AB86BC8A6E13Q27687423-D147A774-6383-488B-B776-B1DD590E8F8CQ28272678-FFF0505D-C2E1-4908-823F-F577859D1AD6Q33904007-A94D0CB7-1D73-4584-89C6-5E97ADE9F1C8Q33920626-3849EC0D-2948-407F-9825-B7DB6B0329E8Q34256150-D1CB49BD-4EDC-4C23-97F5-507DD4C4C6ADQ34265805-B9CF869D-BA73-4B60-B50F-A069A92E9AE5Q34425709-B422801B-50BD-46A2-A334-0909F0BA6AE9Q34612069-8B2DABDD-097E-4F53-9707-9250449CC88BQ34633249-85882429-D50C-40DF-83C0-783EA58AD2BAQ34634386-65E56568-DF1D-4171-9767-ED916D8E6096Q34647076-7C797FE2-3F34-4C78-A5C4-6BF368748A46Q34956865-0DDE9AC3-112A-49F1-98D4-2E71802E1B48Q34993924-F577D8EC-DF47-4833-9469-64F618B32480Q34995738-F86CAB5F-93E9-46F7-AF39-531F3567EBD8Q34998414-A713BF17-E1EA-4DBC-95FE-711FAD6022ACQ35660038-25169750-02FE-476F-9B06-D409D34B44EEQ35829509-1A8029DB-4224-46DF-AAE2-19D8354A9B3EQ36284957-ADA2775A-F613-4712-8742-D297EDC18D4EQ36406952-17AB1A85-CFAA-45F7-B26B-326F56F705A5Q36636630-FCC6BCE1-2F44-4086-933A-BE871C9ACDD1Q36686983-A8440945-1573-4521-872B-B173B6ECED7EQ36746850-7710D794-71F8-4298-9860-5C58304479B7Q36934253-631EFE95-0FAB-4827-8EEA-E5B1C6AF5AEFQ36971961-13596C3B-4ACE-41CD-A7D9-6D480772A839Q37002609-28AF3D59-191C-4754-AC55-B88A7BB162A4Q37189567-5421FDF0-5FC8-4428-8DDF-859565CE94E8Q37760896-DC3C263A-9408-4BDF-93E2-34526E1CE25BQ37972806-A0C23E7B-3670-41D4-A4BA-978A0956F1F5Q37972807-0EECC76B-1AAD-4E2C-88AD-C70386C69B65Q38008950-E67C4565-6C80-4F7B-9024-DF45CB94BB80Q38070128-FBF21BC9-8589-4DC1-A555-125105CEBACAQ38100807-8AB38F22-486E-4CA6-9ADC-EFE1AF25AC73Q38134777-96A6F670-F39E-4495-B363-D889918F784F
P2860
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Postoperative interferon alpha ...... : a randomized clinical trial.
@ast
Postoperative interferon alpha ...... : a randomized clinical trial.
@en
type
label
Postoperative interferon alpha ...... : a randomized clinical trial.
@ast
Postoperative interferon alpha ...... : a randomized clinical trial.
@en
prefLabel
Postoperative interferon alpha ...... : a randomized clinical trial.
@ast
Postoperative interferon alpha ...... : a randomized clinical trial.
@en
P2093
P1476
Postoperative interferon alpha ...... : a randomized clinical trial.
@en
P2093
Bo-Heng Zhang
Hui-Chuan Sun
Lun-Xiu Qin
Qin-Hai Ye
Shuang-Jian Qiu
Xin-Da Zhou
Yong-Bin Qian
P2888
P304
P356
10.1007/S00432-006-0091-Y
P577
2006-03-24T00:00:00Z